retatrutide clinical trials phase trial philippines Lilly's 'triple G' agonist triumphs in III trial, but AEs unnerve analysts Clinical Phase III retatrutide study demonstrates

Although Amgen did not disclose many details, management was encouraged enough to announce that the program will move to phase 3 in obesity, obesity-related indications, and diabetes, an area where theoretical concerns about blood sugar effects of the drug had previously made development less appealing

doi:10.2337/dc13-2759

Results Prolonged GLP-1R Signalling Stimulates Glycolysis via Up-Regulation of Glycolytic Enzymes GLP-1 requires the presence of glucose for stimulation of insulin secretion 14

NAC and glutathione (GSH) do not increase cellular glutathione or, at best, do so marginally only under certain specific conditions